Hologic Announces Partnership with NFL Rookie Kelee Ringo and Family

Hologic Inc. (Nasdaq: HOLX), a global leader in women’s health, today announced a partnership with recently drafted NFL cornerback Kelee Ringo and his mother, breast cancer survivor Tralee Hale, to educate women on the importance of prioritizing annual mammograms and other key health screenings.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230508005184/en/

NFL cornerback Kelee Ringo and his mother, breast cancer survivor Tralee Hale (Photo: Business Wire)

Ringo is a two-time national champion from the University of Georgia who was recently drafted by the Philadelphia Eagles. The launch of the partnership with Hologic is timed with Mother’s Day and National Women’s Health Week (May 14-20, 2023), when Ringo and Hale will share the powerful story of Hale’s breast cancer diagnosis, treatment and recovery.

Hale’s story is a familiar one: a woman who did not prioritize her preventive care screenings as she focused on managing her family, career and other commitments. As a single mother, she was diagnosed with breast cancer just days after Ringo began his freshman year in college. She is now cancer-free after completing treatment, but Ringo and Hale know how lucky they are and want to encourage women not to delay annual screenings.

“Kelee and Tralee’s story resonates with all of us because we have heard from women — time and again — who have prioritized their families and other responsibilities while putting their own health screenings on the back burner,” said Erik Anderson, Hologic’s Division President of Breast and Skeletal Health Solutions. “Hearing how much they mean to one another and how this experience impacted them was incredibly moving. We couldn’t be more grateful that they are sharing their personal story as a way to reach women about the critical importance of annual breast cancer screenings and making their health a priority.”

Breast cancer is the most common cancer diagnosed among women in the United States.¹ However, recent studies show the rate of routine breast cancer screenings has not fully bounced back after sharp declines during the COVID-19 pandemic.² Despite having a similar incidence rate of this disease, Black women in the U.S. are almost 40% more likely to die from breast cancer than non-Hispanic white women.³